Peter Mac’s Professor Monica Slavin, Professor Karin Thursky, Professor Gail Risbridger and Associate Professor Prue Francis have been elected as Fellows of the Australian Academy of Health and Medical Sciences.

They are among 19 women out of the 40 new Ordinary Fellows in the 2019 induction.

The new Fellows have had a significant impact on the health and wellbeing of Australians and the world – representing a broad range of fields from across clinical and biomedical sciences, including infectious diseases, epidemiology and mental health, through to biomedical engineering, health economics and Indigenous health and wellbeing. 

They were elected in recognition of their outstanding contributions to the health and medical research landscape in Australia. 

Prof Monica Slavin, Head of the Department of Infectious Diseases, was elected for her work investigating fungal infections. Her research focus is prevention and early treatment of invasive fungal infections in haematology patients. She has served on national steering committees for the development of antifungal and fever and neutropenia treatment guidelines and for the conduct of Australia-wide studies of the epidemiology of fungal infection.

Prof Karin Thursky, Deputy Head of Infectious Diseases, was elected for her significant contribution to antimicrobial stewardship in Australia. She is internationally recognised as an expert in the area of AMS, particularly in relation to computerised systems.

Professor Gail Risbridger, Head of the Prostate Cancer Program, was elected for her contribution to prostate cancer research and men’s health.  As head of an internationally recognised research team of scientists and clinicians working on prostate cancer and Andrology related projects, she is one of Australia’s leading prostate cancer researchers, with particular interest in the biology of stromal-epithelial cell interactions in normal and tumour tissue using tissue recombination, animal and human specimens. She pioneered the use of stem cells for recombination studies combining stem cell biology with endocrinology.

Associate Professor Prue Francis, Consultant Medical Oncologist, is an internationally renowned breast cancer clinician researcher. She is the Clinical Lead of Breast Medical Oncology at Peter Mac and developed and led the international SOFT randomized trial that resulted in improved overall survival for young women with early breast cancer and resulted in changes to international breast cancer treatment guidelines.

The new Fellows will be admitted at the Academy’s fifth annual meeting on 10-11 October at the Harry Perkins Centre for Medical Research in Perth.